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Abstract
Background Acne vulgaris (AV) is a common dermatological disease affecting almost
85% of teenagers. Patients with AV usually present at community pharmacies during the
early stages of their disease.
Aim The aim of this study was to assess community pharmacists’ knowledge, attitudes,
and practice toward AV management in West Bank in Palestine.
Methods This study was a cross-sectional questionnaire-based study. The questionnaire
included four sections: 1) demographic, 2) knowledge, 3) attitude and practice items
related causes, and 4) treatment options and counseling during management of patients
with AV. A convenience sampling method was implemented in this study. Parametric and
non-parametric tests were used to compare different issues as appropriate. P < 0.05 were
considered significant.
Result A total of 270 community pharmacists were interviewed, and more than half
(54.1%) were males. The study revealed that community pharmacists had an inadequate
level of knowledge on management of AV; only 7.7% had high levels of knowledge.
Pharmacists have positive attitude regarding AV management, but inadequate knowledge
was reflected on their treatment practices; only 10% of participants independently dealt
with AV without referral. Pharmacists with a low level of knowledge showed five times
more referrals than those with a high level of knowledge (OR: 5.3; P < 0.001), and those
with a bachelor degree showed three times more referrals than postgraduates (OR: 3.3;
P < 0.001).
Conclusion There is a demand to update dermatological knowledge of community
pharmacists and encourage them to attend structured training programs about the
management of AV.
Introduction
Acne vulgaris (AV) is a very common skin condition, affecting
85% of teenagers at some point,1 and each year it accounts for 5
million general practitioner (GP) office visits.2 Although acne is
common among teenagers (aged 13–18 years), acne also affects
adults in 15% of women and 5% of men aged over 40 years.3,4
AV can be defined as a chronic inflammatory pilosebaceous dis-
ease that affects the skin by creating lesions in areas rich in large
sebaceous glands; e.g., the face, chest, shoulders and upper
back.5 Propionibacterium acnes (P. acnes) plays a major role in
blocking the follicles and producing inflammatory lesions. Lesions
characterized by comedones, papules, pustules, inflamed
nodules, which sometimes heal with scarring and pigmentation,
may lead to considerable psychological distress.6 Psychological
distress such as embarrassment, poor self-image, lack of
self-esteem, anxiety, and avoidance of social activities with peers
have been reported.7–10
The severity of AV can be classified into mild, moderate, and
severe based on the number and type of lesions.11 The pathogen-
esis of AV is influenced by the interaction of environmental and
genetic factors, which may be responsible for the appearance of
AV within a family or community.12 Spencer et al13 reported in their
systematic review that dairy products (foods rich in carbohydrates,
chocolate) increase the risk for acne. In addition, it is also known
that steroids, neuro-psychotherapeutics, and immunomodulatory
drugs increase the risk of acne.13 Other risk factors might be con-
sidered as contributing factors to the prevalence and severity of
acne including physiological factors such as the menstrual cycle,
pregnancy, anxiety, and depression.14
The prevalence and incidence of acne varies depending on
the study populations and the method of estimation used. In
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one study conducted in the UK, they reported the prevalence of
AV in a community sample of 14- to 16-year-olds as 50%.14
The other study in New Zealand reported that the estimated
prevalence of AV among students was found to be 91% of
males and 79% of females, and in a similar population in Portu-
gal, the prevalence of AV was 82%.15,16
The mainstay therapy for treatment of mild-to-moderate acne
is over-the-counter (OTC) topical medications. Benzoyl peroxide
is the most commonly used treatment for acne and is available
in a variety of strengths and formulations.17 Other topical agents
include salicylic acid, tretinoin, isotretinoin, and antimicrobial
ointments.18,19 Systemic therapy that includes oral tetracycline,
minocycline, hormones, and retinoids indicated the treatment of
moderate-to-severe cases.20 Early treatment of AV is very cru-
cial for disease remission, prevents scars, and minimizes psy-
chological impact.19
Community pharmacists in an ideal position play a major role
in recommending appropriate treatment for those with mild-to-
moderate cases and referral of severe cases for further evalua-
tion.21 Knowledge of pharmacist plays a critical role in effective
treatment of AV and its psychological implications; therefore,
this study was conducted among pharmacists working at com-
munity pharmacies in the West Bank, to explore their knowl-
edge, attitude, and practice for acne management.
Methods
Study design
The study was a cross-sectional questionnaire-based survey,
which surveyed the licensed working Palestinian pharmacists
who registered at the Palestinian Pharmaceutical Syndicate
(PPS).
Study population and sampling procedure
This study was carried out in different districts in the West Bank
in Palestine – Central (Ramallah and East Jerusalem), North
(Nablus and Tulkarm), and South (Betlehem and Hebron). A
convenience sampling procedure was involved in this research.
Community pharmacies located in cities, villages, and refugee
camps in different governorates were visited, and only one
pharmacist was invited to participate in the study. The
pharmacists were interviewed by researchers who are expert in
the research field. The data were collected from December
2018 to February 2019.
Sample size
The sample size selected from each governorate is
proportionate to the relative size of that governorate in the
study population. The total number of community pharmacies
in all studied governorates was 1019 pharmacies; the sample
size was calculated using Raosoft sample size calculator,
with a predetermined margin of error of 5% and CI level of
95%. Only one pharmacist was recruited from each
pharmacy, and the minimum recommended sample size was
256 pharmacists. A total of 280 questionnaires were
distributed; however, 270 questionnaires were included in final
analysis.
Data collection form
A semi-structured questionnaire with closed-ended questions
was developed using the precedence set by similar studies.22,23
The questionnaire comprised four sections; in the first section,
questions on sociodemographics were requested. The second
section comprised 11-item knowledge questions to assess the
pharmacists’ level of knowledge in the treatment of acne
vulgaris. Each correct answer carried (1) point and a zero point
for wrong answer. The levels were determined on a range of
(0–4) as low level, (5–8) as moderate level, and (9–11) as high
level. The third section comprised 5-item statements to explore
the pharmacists’ practices in counseling and treating acne
vulgaris patients. The fourth section comprised 5-item
statements to explore the pharmacists’ attitudes while treating
acne vulgaris.
The content of the questionnaire was reviewed by a panel of
three specialist/professors who are expert in pharmaceutical
researches for face validity, and it was piloted among 15
pharmacists in order to judge the time needed for administration
and to test for clarity and reliability. The questionnaires used in
the pilot study were not included in the final statistical analysis.
Data analysis
The data were analyzed using the Statistical Package for Social
Sciences (SPSS; version 23, SPSS, Chicago, IL, USA) for data
screening, descriptive statistics, and univariate analysis. Data of
the study were presented with descriptive measures such as
means and numbers with percentages and/or graphical
presentations for categorical variables. Chi-squared test was
also used to explore the association between categorical
variables at P < 0.05 significant level.
Ethical considerations
The study protocol was revised and approved by both the
ethics committee of Al-Quds University and the Palestinian
Pharmaceutical Syndicate. An explanation of the study rationale
was provided, and pharmacists confirmed that the survey would
measure knowledge and practice regarding AV. Willingness to
participate was a fundamental condition in the study.
Results
Demographic characteristics of participant
A total of 315 pharmacists were approached and asked to par-
ticipate in the study; however, 270 agreed to fill out the forms
with a response rate of 85.7%. Of the 270 pharmacists, 146
(54.1%) were males. The highest percent of participants (167,
61.9%) were between the ages of 23 and 35. The majority of
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participants (223, 82.6%) had a bachelor degree in pharmacy,
whereas 45 (16.7%) had a master of pharmaceutical sciences.
One-third of the participants (94, 33.6%) had 5 years or less of
experience (Table 1).
Knowledge
The 11 knowledge items were tested; the median score of knowl-
edge on causes, pathophysiology, and treatment of AV was
found to be 5.88 (interquartile range: 4.9–7.1). The overall levels
of the pharmacists’ knowledge on the AV managements are sum-
marized in Figure 1, which shows that the majority of community
pharmacists had moderate levels of knowledge (69.3%) and only
7.7% had a high level of knowledge about AV management.
Response of community pharmacists to questions on the
causes and physiological problem of AV is illustrated in Figure 2.
The majority of pharmacists (88.3%) reported that it is a hor-
monal problem, 85.6% reported that it is a bacterial infection,
and 57.9% believed that it is caused by drug use.
The majority of participated community pharmacists reported
that the most used medication for the treatment of AV in gen-
eral is topical antibiotic (67.1%), and 96% of the pharmacists
believed in not using topical antifungal agents in the treatment
of AV (Fig. 3).
When we asked the pharmacist about the treatment of mild
acne, half of the participants (50.4%) preferred to use benzoyl
peroxide lotion and 34.4% preferred salicylic acid ointment.
Other treatments are shown in Table 2.
Participating community pharmacists indicated that they rely
on pharmacy textbooks (39.1%) and internet (31.2%) as their
first choice for information resources; while 25.6% of them were
depending on the information that is given by the dermatologists
or medical representative person.
Practice of acne management
Evaluating the Palestinian pharmacists’ practice toward manage-
ment of AV, 72% of them agreed that the treatment duration
should be more than 1 month. About 65% of the participants
admitted to follow-up of their patients, and 90% of the pharmacists
preferred to refer patients with severe acne to a dermatologist.
Regarding patients’ counseling for AV, 88% of the pharmacists
gave advice for diet modification, 60% asked the patient to avoid
manipulating pimples, 67% encouraged the patients to take care
of skin and facial hygiene, 54% enhance for stress relief, 74%
educated their patients to adhere to the therapy (Table 3).
Concerning the community pharmacists’ characteristics asso-
ciated with referral patients with AV to physician/specialist,
Table 4 shows that levels of knowledge and qualification were
significantly (P < 0.05) associated with the number of referral
patients. Community pharmacists with low level of knowledge
made five times referrals more often than did those with higher
levels (OR: 5.3; P < 0.001). Community pharmacists with a
bachelor degree made three times more referrals than those
with a master’s degree (OR: 3.3; P < 0.001).
Attitudes and behaviors
Concerning our participants’ responses on their attitudes toward
management of patients with AV, the participants showed a
good attitude while treating AV. About 90.7% of the community
pharmacists ask the patients about pregnancy or planning for
pregnancy, 83% ask female patients for the hormonal regularity,
and 81.9% ask the patients for their medical and medication
Table 1 Demographic characteristics of participant
community pharmacists included in the study
Variable N (%)
Gender
Male 146 (54.1)
Female 124 (45.9)
Age (years)
23–35 167 (61.9)
36–45 64 (23.7)
46–55 29 (10.7)
>56 10 (3.7)
Education level
Bachelor degree 223 (82.6)
Master degree 45 (16.7)
PhD 2 (0.7)
Years of experience
1–5 94 (33.6)
6–10 84 (30.0)
11–15 45 (16.7)
>15 47 (16.8)
Location of the pharmacy
City 178 (65.9)
Village 86 (31.8)
Camp 6 (2.2)
Job
Owner 153 (56.7)
Employee 117 (43.3)
23.0%
69.3%
7.7%
Low
Moderate
High
Figure 1 Pharmacists’ levels of knowledge about the management
of acne vulgaris
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history. Only 47.8% ask the patients for their family history
regarding AV (Table 5). The data show community pharmacists
have a good attitude on the treatment of AV but need to
increase asking about family history regarding AV.
Finally, when we asked the pharmacists about the challenges
faced them while treating or counseling patients with AV, sev-
eral real challenges were reported. The major challenges were
poor pharmacist–patient communication due to limited space in
the pharmacy (66%), lack of experience in the management of
AV (62%), and difficulty to access the latest treatment guideli-
nes for AV (61%).
Discussions
To the best of our knowledge, this was the first study to explore
the knowledge, attitude, and management of AV among com-
munity pharmacists in the West Bank, Palestine. In general,
two-thirds of community pharmacists had relatively moderate
knowledge scores on AV management.
Similarly, almost two-thirds of pharmacists in Zambia cor-
rectly answered the terms regarding the management of AV.22
Another study conducted on primary care physicians reported
that 70% of primary healthcare physicians had insufficient
knowledge regarding common dermatological disorders,
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Figure 2 Pharmacists’ levels of knowledge
on causes of acne vulgaris
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Figure 3 Drugs commonly used in the
management of acne
Table 2 Drugs commonly used for managing mild acne
Type of medication N (%)
Benzoyl peroxide lotion 136 (50.4)
Salicylic acid ointment 93 (34.4)
Topical retinoid 80 (29.6)
Sulfur-based soap 52 (19.3)
Others 41 (15.2)
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whereas 22% of them had good knowledge and only 5% had
excellent knowledge.23 The British American Dermatologist
Association of 2007 found primary physicians and pharmacists
lack the adequate knowledge regarding AV management.24
The participants in the present study reported that hormone
disturbances are the major cause of AV. This is inconsistent
with other studies in which hormone disturbances provide the
initial trigger for the onset of acne.25,26 It was evident by many
studies that acne is a result of P. acnes.27 However, the patho-
genesis of AV is multifactorial, which may be caused by genetic
factors, diets, stress, cosmetics, and drugs.28–31
Regarding community pharmacists’ practices to manage AV
in the West Bank, a wide range of modalities are available for
treating mild-to-moderate acne. They usually prescribe benzoyl
peroxide lotion, salicylic acid ointment, and/or acne soap. Topi-
cal retinoid was recommended by only 19.3% of the participants
despite the international guidelines which consider topical reti-
noid as the first-line treatment, alone or in combination, for mild-
to-moderate inflammatory cases.32
More than two-thirds of community pharmacists agreed that
treatment should last for more than a month, which is inconsis-
tent with international guidelines. Other recommended practices
– counseling their patients to adhere to medication; stress on
avoidance of manipulating pimples; avoiding diets, emotional
stress, and environmental factors that trigger AV – were per-
formed by a majority of participants.33
We found that 90% of the participants may refer acne cases
to the physician/specialist; this high percentage referral rate in
our sample could be explained by low focus in continuing care
and lack of counseling skills. The present study showed that
pharmacists with low level knowledge and bachelor degree
pharmacists have higher referral rates (P < 0.01) compared
with high levels of knowledge and those who had a master’s
degree. Lack of knowledge, counseling skills, and proper com-
munications among community pharmacists were reflected in
their practices; only one quarter can manage AV independently
at their pharmacies.
In the last two decades, a pharmacist’s role expanded from
product oriented to patient focus oriented.34,35 Pharmacists
should have communication skills and should counsel acne
patients on available products, treatment use, the important of
adherence, and likely side effects such as dryness and irritation.
Pharmacists are in an ideal position to make a valuable coun-
seling to the care of patients with AV though this role needs to
be more clearly defined.36
Nevertheless, our community pharmacists have positive atti-
tudes and behaviors regarding the management of AV. On the
contrary, many studies showed negative attitude by both
Table 3 Practice of acne management among community
pharmacists
Practices Values N (%)
What is the average duration
of treatment in AV
1 week 4 (2)
2–4 weeks 72 (27)
More than 1 month 193 (72)
Follow-up your AV patients Yes 175 (65)
No 95 (35)
Refer patients with acne for
dermatologist
Yes 200 (90)
No 70 (10)
How do you treat patients with
severe AV?
Refer to dermatologist
without any intervention
174 (64)
Provide advice only 25 (10)
Prescribe medications by
your own
71 (26)
Other advices that you provide
to the patient with AV
Frequent facial washing 181 (67)
Adhere to treatment
regimen
200 (74)
Avoid manipulating pimples 163 (60)
Avoid stress 147 (54)
Diet modification 237 (88)
Table 4 Referral of acne patients by participating
pharmacists in relation to their knowledge, experience, and
qualification
Variables (n)
Referral
(yes, n = 200) OR (CI 95%)
P
value
Knowledge level
High (n = 21) 7 (33.3) 1.0a 0.001
Moderate (n = 187) 142 (75.9) 2.2 (1.2–6.3)
Low (n = 62) 51 (82.3) 5.3 (2.4–9.9)
Working experience
1–5 years (94) 67 (71.2) 1.0a 0.117
6–10 years (84) 62 (71.4) 1.1 (0.4–1.9)
11–15 years (45) 36 (80.0) 1.6 (0.3–2.2)
>15 years (47) 35 (74.5) 1.2 (0.5–1.8)
Qualifications
Master/PhD degree (47) 24 (51.1) 1.0a 0.001
Bachelor degree (223) 176 (78.9) 3.3 (1.41–5.26)
Gender
Male (146) 103 (70.5 1.0a 0.121
Female (124) 97 (78.2) 1.4 (1.1–2.4)
CI, confidence interval; OR, odds ratio.
aReference group.
Table 5 Pharmacist’s attitude on the treatment of acne
vulgaris
Practices Values N (%)
Asking about patients medical and medication
history
Yes 221 (81.9)
No 49 (18.1)
Asking about patients family history regarding AV Yes 129 (47.8)
No 141 (52.2)
For female: asking about hormonal regularity Yes 224 (83.0)
No 46 (17.0)
Asking about pregnancy or planning for
pregnancy
Yes 245 (90.7)
No 25 (9.2)
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provider and patients due to sociopsychological factors on acne
and other skin conditions.36 About 91% of the community phar-
macists ask the patients about pregnancy or planning for preg-
nancy, 83% ask female patients for the hormonal regularity, and
82% ask the patients for their medical and medication history.
However, community pharmacists need to improve their coun-
seling on asking about patient and family medical history
regarding AV.
Several challenging factors such as poor pharmacist–patient
communication due to limited space in the pharmacy and gen-
der embarrassment,37 lack of experience in the management of
AV, and difficulty to access the latest treatment guidelines for
AV were reported by participant pharmacists. This calls for
more educational programs to community pharmacists through
continuing education and professional development and the
need for development of national guidelines for treatment of AV.
Study Limitations
This study was conducted only on community pharmacists; the
exclusion of hospital pharmacists and primary care pharmacists
might limit the generalizability of the study. Even though a suffi-
cient sample size was recruited and conducted only in the West
Bank, the opinions expressed may not be representative of all
pharmacists in Palestine. Furthermore, the use of a question-
naire-based study may create problems in question understand-
ing (over- or under-evaluating), which can lead to a possible
information bias.
Conclusion
The present study showed that community pharmacists have a
positive attitude and practice on the treatment of AV, but they
need to increase their knowledge. Only 7.7% had high knowl-
edge, while a large proportion of Palestinian pharmacists was
within the medium and basic level of knowledge. Pharmacists
play a critical role as healthcare providers, counseling patients
on appropriate medication, drug-induced acne, drug safety, and
drug interactions. Better knowledge, perception, and practice
are very important for the development of national guidelines
and to clearly define the pharmacist’s role in the management
of AV. Besides, there is a demand to encourage the pharma-
cists to attend structured professional training programs about
the management of AV.
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